Jade Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	55.09	88.44	69.39	23.49	22.4	54.2
Short-Term Investments	256.21	247.72	-	98.95	106.82	113.18
Cash & Short-Term Investments	311.3	336.16	69.39	122.44	129.22	167.38
Cash Growth	308.47%	384.47%	-43.33%	-5.25%	-22.80%	3560.07%
Other Current Assets	7.22	12.66	0.27	1.79	2.28	6.96
Total Current Assets	318.52	348.82	69.65	124.23	131.5	174.33
Net Property, Plant & Equipment	0.85	0.9	-	0.9	1.25	0.73
Other Long-Term Assets	0.07	0.07	3.15	2.28	2.56	0.3
Total Assets	319.43	349.78	72.8	127.42	135.3	175.36
Accounts Payable	3.98	2.15	1.29	2.4	2.58	1.21
Accrued Expenses	15.65	14.39	9.63	14.82	4.82	1.15
Current Portion of Leases	-	-	-	0.42	0.39	0.19
Other Current Liabilities	2.67	-	1.08	-	-	-
Total Current Liabilities	22.29	16.54	12	17.64	7.78	2.55
Long-Term Debt	-	-	107.6	-	-	-
Long-Term Leases	0.68	0.72	-	0.26	0.71	0.38
Other Long-Term Liabilities	-	-	-	0.07	0.07	0.01
Total Long-Term Liabilities	0.68	0.72	107.6	0.33	0.78	0.4
Total Liabilities	22.97	17.26	119.6	17.96	8.56	2.95
Preferred Stock	0	0	-	-	-	-
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-in Capital	511.55	506.77	0.18	272.64	215.11	208.87
Accumulated Other Comprehensive Income	-0.34	0.13	-	0.24	-0.47	-0.06
Retained Earnings	-214.76	-174.39	-46.98	-163.42	-87.9	-36.39
Total Common Shareholders' Equity	296.46	332.52	-46.8	109.46	126.74	172.42
Minority Interest	-	-	0	-	-	-
Shareholders' Equity	296.46	332.52	-46.8	109.46	126.74	172.42
Total Liabilities & Equity	319.43	349.78	72.8	127.42	135.3	175.36
Total Debt	0.68	0.72	107.6	0.68	1.09	0.57
Net Cash (Debt)	310.62	335.43	-38.21	121.76	128.13	166.8
Net Cash Growth	-7.40%	-	-	-4.97%	-23.18%	3547.52%
Net Cash Per Share	6.91	10.70	-46.80	161.85	183.25	474.88
Book Value	296.46	332.52	-46.8	109.46	126.74	172.42
Book Value Per Share	6.60	10.60	-57.31	145.49	181.27	490.88
Tangible Book Value	296.46	332.52	-46.8	109.46	126.74	172.42
Tangible Book Value Per Share	6.60	10.60	-57.31	145.49	181.27	490.88

SEC Filings: 10-K · 10-Q